Abstract |
A number of studies have implicated a proline-directed protein kinase, glycogen synthase kinase-3 (GSK-3) in the hyperphosphorylation of tau in Alzheimer's disease (AD). Toward understanding the role of GSK-3 in the abnormal hyperphosphorylation of tau in AD we have found that GSK-3 is prominently present in neuronal cell bodies and their processes and co-localizes with neurofibrillary changes in AD brain. Furthermore, the levels of GSK-3 as determined by indirect ELISA are approximately 50% increased in the postsynaptosomal supernatant from AD brains as compared to the controls. However, no increase in GSK-3 enzyme activity was detected. In AD brain, with its reduced phosphatase activity, even normal levels of GSK-3 activity might be sufficient for the hyperphosphorylation of tau.
|
Authors | J J Pei, T Tanaka, Y C Tung, E Braak, K Iqbal, I Grundke-Iqbal |
Journal | Journal of neuropathology and experimental neurology
(J Neuropathol Exp Neurol)
Vol. 56
Issue 1
Pg. 70-8
(Jan 1997)
ISSN: 0022-3069 [Print] England |
PMID | 8990130
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Nerve Tissue Proteins
- Recombinant Proteins
- tau Proteins
- Glycogen Synthase Kinases
- Calcium-Calmodulin-Dependent Protein Kinases
- Glycogen Synthase Kinase 3
- Phosphoprotein Phosphatases
|
Topics |
- Alzheimer Disease
(enzymology, pathology)
- Animals
- Brain
(enzymology, pathology)
- Calcium-Calmodulin-Dependent Protein Kinases
(metabolism)
- Cattle
- Cerebral Cortex
(enzymology, pathology)
- Glycogen Synthase Kinase 3
- Glycogen Synthase Kinases
- Hippocampus
(enzymology, pathology)
- Humans
- Nerve Tissue Proteins
(metabolism)
- Neurofibrillary Tangles
(enzymology)
- Neurons
(enzymology, pathology)
- Phosphoprotein Phosphatases
(deficiency)
- Phosphorylation
- Protein Processing, Post-Translational
- Recombinant Proteins
(metabolism)
- tau Proteins
(genetics, metabolism)
|